Home > Boards > US OTC > Biotechs >

China Dasheng Biotech (CDBT)

CDBT RSS Feed
Add CDBT Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 3/24/2022 10:56:36 AM - Followers: 21 - Board type: Free - Posts Today: 0

 

Company Overview:

The Company derives its revenues from the sale of products in the biological products and agents market. All revenues generated are from sales to customers in China. The Company has two majority-owned subsidiaries in China. It has 80% interest in Hainan Lüshen Biology Technology Co., Ltd. (“Lüshen”) located in HaiKou, Hainan Province, China. Lüshen engages in developing, manufacturing and marketing artificial microorganisms (“AM”), high-efficiency microorganism (“HM”) based biological bacterium blends, and biological preservatives. The Company also has a 60% interest in Yangling Elemiss Foods Co., Ltd. (“Elemiss”) located in City of Yangling, Shaanxi Province, China. Elemiss engages in developing, manufacturing and marketing artificial microorganism (“AM”) based biological bacterium blends, and Bulgarian lactobacillus live stock feed additives. The Company had two joint ventures for real estate projects in China to develop commercial and residential real estate in China. The Company’s ownership interests in the two ventures are 17.5% and 16.5%, respectively. As a result, the Company accounts for these two ventures based on cost method of accounting.

The Company has been formally approved by the local tax bureau for the favorable tax benefit enjoyed by the foreign invested company, which allows two-year tax exemption of income tax from January 20, 2008 through January 19, 2010, and three-year 50% tax reduction from January 20, 2010 to January 19, 2013.

Overall, the Company is still enjoying remarkable market demand for its products in a relatively stable domestic market environment. Management’s focus has been on cost control to reduce expenses and thereby to boost profit margin.

The table below shows a breakdown of net sales by products as a percentage of total revenue for the first three quarters on both fiscal 2008 and fiscal 2009:

    Net Sales and Percentage on 2008     Net Sales and Percentage on 2009  
Product Line                        
AM/HM Crop Additives $ 6,658,568     58.30%   $ 9,115,576     56.70%  
AM/HM Livestock Additives $ 4,237,270     37.10%   $ 5,723,368     35.60%  
FGW Preservatives $ 525,377     4.60%   $ 1,237,918     7.70%  
Total $ 11,421,215     100%   $ 16,076,862     100%  

 

Chairman & CEO:  Jinjun Qi

Jinjun Qi is the Chairman of China Da Sheng Biotechnology Co., director of Gansu DS-Biology Engineering Research Institute and President of Gansu DS-Biology Science and Technology Stock Co. DS Group is based in New York City and its headquarters are in Gansu Province, China. Mr. Qi is a well respected economist and agronomist who has made significant contributions to revitalizing China’s agricultural industry through science and technology. Currently DS is working on a project in the U.S. to convert soil to fertilizer. Under Mr. Qi’s leadership DS Group has received numerous awards inside China. In 2008, he received a “Certificate of Appreciation” from the U.S. Department of Commerce.

Mr. Qi received a B.S. in from Gansu Agricultural University, a graduate degree from the Business Administration College of Lanzhou University, and graduate degree in economics from Gansu Provincial Committee Party School and M.B.A degrees from Tsinghua University and Australia National University.

 

Link to latest 10-Q:  http://www.sec.gov/Archives/edgar/data/1393067/000120445909000874/dasheng10q.htm

 

Total revenue grew approximately 43% to $5.3 million in the third quarter of 2009, compared with $3.7 million in the prior year quarter; -- Gross margin improved by 50% to $2.6 million in the third quarter of 2009, compared with $1.8 million in the prior year quarter; -- Operating expenses, as a percentage of revenue, were reduced by over 900 basis points to 20.2% in the third quarter of 2009, compared to 29.9% in the prior year quarter; -- Income from operations increased by 140% to $1.6 million in the third quarter of 2009, compared to $0.7 million in the prior year quarter; -- Net income rose over 200% to $1.3 million in the third quarter of 2009, or $0.04 per diluted share, compared with $0.4 million, or $0.01 per share in the prior year quarter; -- $10.4 million of cash on the balance sheet as of the quarter end, March 31, 2009.

Company Website:  http://www.chinadashengbio.com/    Alternate site:  http://english.gsdsjt.com/index.html

Investor Relations:  CSIR Group, LLC  Website:  http://csirgroup.com/  Contact:  Christine Petraglia  Phone:  646-354-8886  E-mail:  christine@csirgroup.com

Current Valuation:  at the current PPS of .34, the ttm P/E is 1.7 (updated daily)

  

NEWS

The current agriculture policy is benefit to product & sale of our Company’s or  21/4/2009
The company established eight sales districts for market   21/4/2009
No pay cuts, no staff cuts, sales quantity increased steadily--- Dasheng Company  21/4/2009
SEC verified and approved company’s the second quarter audit report  21/4/2009
The tenth annual summit of growing China  21/4/2009

REPORTING

05/18/2009 8:39AM PRNUS China Dasheng Biotechnology Company Reports Unaudited Third Quarter FY2009 Financial Results
05/14/2009 3:31PM EDGAR (10-Q) - Quarterly Report
02/19/2009 1:21PM EDGAR - Amended Quarterly Report (10-Q/A)
02/12/2009 12:06PM EDGAR (10-Q) - Quarterly Report
02/10/2009 8:00AM PRNUS China Dasheng Biotechnology Company (CDBT.OB) Pre-Announces Fiscal Year 2009 Second Quarter Earnings
CDBT
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PostSubject
#457   Might have to slap those 14s, could be rjack18 03/24/22 10:56:36 AM
#456   Thank you tradenride 03/24/22 10:29:29 AM
#455   Sell me your 10s tradenride 03/24/22 09:54:45 AM
#454   Order granting the motion to approve cancellation of LPK3 03/24/22 08:03:33 AM
#453   Yes, expect a nice pop ahead of the rjack18 03/09/22 12:29:47 PM
#452   Nevada SOS Certificate of Correction filed today LPK3 03/09/22 09:26:20 AM
#451   Next court date 3/22. Things will start getting LPK3 02/25/22 10:19:04 AM
#450   Looks like a change in stock https://esos.nv.gov/EntitySearch/BusinessFilingHist LPK3 02/25/22 10:16:56 AM
#449   Court date 3/22 LPK3 02/22/22 10:19:11 AM
#448   21 million share cancellation coming? https://www.clarkcountycourts.us/Portal/Ca LPK3 02/19/22 01:18:46 PM
#447   It looks like our next move up will rjack18 11/10/21 04:27:19 PM
#446   Agreed, some people need to learn the hard LPK3 11/10/21 03:45:34 PM
#445   Somebody wants out. It amazes me how many rjack18 11/10/21 03:25:24 PM
#444   Pink current! LPK3 11/09/21 05:32:58 AM
#443   Aweosme. Some .29 hitting now ProfitChaser 10/18/21 09:53:40 AM
#442   Pink limited … we’re off expert woo Fenderputty 10/18/21 03:32:14 AM
#441   Profile verified rjack18 10/15/21 05:41:21 PM
#440   True. fink 10/01/21 10:52:58 AM
#439   It was yield sign on the 27th. Just Fenderputty 10/01/21 10:44:54 AM
#438   Pure Wisdom fink 10/01/21 10:11:17 AM
#437   I have noticed the dip comes in a Mr. Zen 10/01/21 08:21:03 AM
#436   CDBT 9m float Expert Market with all filing fink 09/30/21 06:52:49 PM
#435   that's one sixth of the float that changed horst 09/17/21 03:26:52 PM
#434   Looks good. Picked up a starter at open ProfitChaser 09/17/21 11:32:44 AM
#433   Frank has two, cbbt & wyph low float MetaverseProfits 09/17/21 10:15:44 AM
#432   Who is putting out the effort to keep fink 09/17/21 10:03:39 AM
#431   Yield sign is up, and shell status is horst 09/17/21 09:29:58 AM
#430   Thanks - annual reports and an attorney letter horst 09/16/21 11:58:35 PM
#429   Attorney letter out LPK3 09/16/21 08:16:40 PM
#428   Best share structure/cheap market cap combo of any horst 09/16/21 10:40:31 AM
#427   Filings starting to hit! aristotelisonassis 09/16/21 03:14:16 AM
#426   Director(s) Added: Golden_Cross 07/29/21 02:02:28 PM
#425   Well 2 custody awards to 2 different littlejohn 07/23/21 01:59:22 AM
#424   I think so, I have seen many processing Golden_Cross 07/02/21 06:58:22 AM
#423   Was following Bryan Clark application using littlejohn 07/02/21 01:31:51 AM
#422   Yes, moving forward here $CDBT Golden_Cross 06/28/21 03:49:04 AM
#421   is that a good thing?... littlejohn 06/27/21 10:00:10 PM
#420   President Added: Frank Ikechukwu Igwealor Golden_Cross 06/26/21 08:01:36 AM
#419   Yup good movement off of RE Fenderputty 06/25/21 11:09:34 PM
#418   Certificate of reinstatement filed. LPK3 06/25/21 06:00:36 PM
#417   CDBT Case Information Golden_Cross 06/22/21 06:37:04 PM
#416   Agreed. It’ll come and it’ll be fun LPK3 06/22/21 02:06:56 PM
#415   Volume was larger before the confirmation lol … It’s Fenderputty 06/22/21 02:05:48 PM
#414   We will have people who catch it on LPK3 06/22/21 01:57:13 PM
#413   Think volume stays kinda low until alpha tweets maybe?? Fenderputty 06/22/21 01:55:31 PM
#412   custodianship granted LPK3 06/22/21 01:45:57 PM
#411   they snatched shell control from their littlejohn 06/17/21 02:46:56 PM
#410   You still need to deal with the past fink 06/17/21 01:45:48 PM
#409   Why does the China connection matter if it’s Fenderputty 06/17/21 01:35:57 PM
#408   The worst thing about this is the China fink 06/17/21 10:49:34 AM
PostSubject
Consent Preferences